Plerixafor
| CAS No. | 110078-46-1 | Cat. No. | BCP02337 |
| Name | Plerixafor | ||
| Synonyms | JM-3100; JM 3100; JM3100; AMD-3100; AMD 3100; AMD3100; | ||
| Formula | C28H54N8 | M. Wt | 502.78 |
| Description | Plerixafor inhibits CXCL12-mediated chemotaxis with a potency lightly better than its affinity for CXCR4. Plerixafor also antagonizes SDF-1/CXCL12 ligand binding with an IC50 of 651 nM. Plerixafor inhibits SDF-1 mediated GTP-binding, SDF-1 mediated calcium flux and SDF-1 stimulated chemotaxis with IC50 of 27 nM, 572 nM and 51 nM, respectively. Plerixafor does not inhibit calcium flux against cells expressing CXCR3, CCR1, CCR2b, CCR4, CCR5 or CCR7 when stimulated with their cognate ligands, nor does Plerixafor inhibit receptor binding of LTB4. Plerixafor does not, on its own, induce a calcium flux in the CCRF–CEM cells, which express multiple GPCRs including CXCR4, CCR4 and CCR7. | ||
| Related Products | 155148-31-5（Plerixafor octahydrochloride） 155148-32-6（Plerixafor Octahydrobromide） | ||
| Pathways | GPCR/G Protein | ||
| Targets | CXCR | ||
|
Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis
Publications Citing of Biochempartner's Plerixafor(CAS:110078-46-1) |
|
Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes
Publications Citing of Biochempartner's Plerixafor(CAS:110078-46-1) |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.